{"entity":{"type":"insider","cik":"0001422484","url":"/insider/0001422484","json_url":"/insider/0001422484.json","name":"Mackaness James H","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":96,"n_filings":38,"first":"2009-03-13","last":"2025-03-31","span_basis":"filed_date"},"name_variants":[{"name":"Mackaness James H","source":"filing","n_filings":38,"first_seen":"2009-03-13","last_seen":"2025-03-31"}],"transactions":[{"id":4108552,"accession":"0001415889-25-009295","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001415889-25-009295","line_url":"/filing/0001415889-25-009295","is_derivative":false,"issuer_cik":"0001422484","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001422484","owner_cik":"0001422484","owner_name":"Mackaness James H","owner_display_name":"Mackaness James H","owner_url":"/insider/0001422484","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":90622.0,"shares_display":"90,622","price_per_share":69.44425229524839,"price_display":"69.44","price_state":"stated","total_value":6293177.0315,"total_display":"6,293,177.03","total_whole":"6,293,177","shares_owned_after":113220.0,"shares_owned_after_display":"113,220","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-27","filed_date":"2025-03-31","scope":"insider","n_lines":11},{"id":4035454,"accession":"0001415889-25-000955","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-000955","line_url":"/filing/0001415889-25-000955#line-3","is_derivative":false,"issuer_cik":"0001422484","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001422484","owner_cik":"0001422484","owner_name":"Mackaness James H","owner_display_name":"Mackaness James H","owner_url":"/insider/0001422484","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3791.0,"shares_display":"3,791","price_per_share":46.1764,"price_display":"46.18","price_state":"stated","total_value":175054.7324,"total_display":"175,054.73","total_whole":"175,055","shares_owned_after":111298.0,"shares_owned_after_display":"111,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-03","filed_date":"2025-01-06","scope":"insider"},{"id":4035451,"accession":"0001415889-25-000955","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-000955","line_url":"/filing/0001415889-25-000955","is_derivative":false,"issuer_cik":"0001422484","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001422484","owner_cik":"0001422484","owner_name":"Mackaness James H","owner_display_name":"Mackaness James H","owner_url":"/insider/0001422484","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4083.0,"shares_display":"4,083","price_per_share":45.40918618662748,"price_display":"45.41","price_state":"stated","total_value":185405.7072,"total_display":"185,405.71","total_whole":"185,406","shares_owned_after":115410.0,"shares_owned_after_display":"115,410","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-02","filed_date":"2025-01-06","scope":"insider","n_lines":2},{"id":2711835,"accession":"0001415889-24-024664","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-024664","line_url":"/filing/0001415889-24-024664","is_derivative":false,"issuer_cik":"0001422484","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001422484","owner_cik":"0001422484","owner_name":"Mackaness James H","owner_display_name":"Mackaness James H","owner_url":"/insider/0001422484","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8077.0,"shares_display":"8,077","price_per_share":49.429415315092236,"price_display":"49.43","price_state":"stated","total_value":399241.3875,"total_display":"399,241.39","total_whole":"399,241","shares_owned_after":120001.0,"shares_owned_after_display":"120,001","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-01","filed_date":"2024-10-03","scope":"insider","n_lines":2},{"id":3237457,"accession":"0001415889-24-022650","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-022650","line_url":"/filing/0001415889-24-022650","is_derivative":false,"issuer_cik":"0001422484","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001422484","owner_cik":"0001422484","owner_name":"Mackaness James H","owner_display_name":"Mackaness James H","owner_url":"/insider/0001422484","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6870.0,"shares_display":"6,870","price_per_share":47.284557423580786,"price_display":"47.28","price_state":"stated","total_value":324844.9095,"total_display":"324,844.91","total_whole":"324,845","shares_owned_after":128524.0,"shares_owned_after_display":"128,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-29","filed_date":"2024-08-30","scope":"insider","n_lines":2},{"id":3237447,"accession":"0001415889-24-022650","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-022650","line_url":"/filing/0001415889-24-022650","is_derivative":false,"issuer_cik":"0001422484","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001422484","owner_cik":"0001422484","owner_name":"Mackaness James H","owner_display_name":"Mackaness James H","owner_url":"/insider/0001422484","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6661.0,"shares_display":"6,661","price_per_share":47.58111223540009,"price_display":"47.58","price_state":"stated","total_value":316937.7886,"total_display":"316,937.79","total_whole":"316,938","shares_owned_after":137219.0,"shares_owned_after_display":"137,219","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-28","filed_date":"2024-08-30","scope":"insider","n_lines":2},{"id":2132434,"accession":"0001415889-24-020945","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001415889-24-020945","line_url":"/filing/0001415889-24-020945","is_derivative":false,"issuer_cik":"0001422484","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001422484","owner_cik":"0001422484","owner_name":"Mackaness James H","owner_display_name":"Mackaness James H","owner_url":"/insider/0001422484","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8134.0,"shares_display":"8,134","price_per_share":45.45562862060487,"price_display":"45.46","price_state":"stated","total_value":369736.0832,"total_display":"369,736.08","total_whole":"369,736","shares_owned_after":140780.0,"shares_owned_after_display":"140,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-06","filed_date":"2024-08-07","scope":"insider","n_lines":3},{"id":2132423,"accession":"0001415889-24-020945","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-020945","line_url":"/filing/0001415889-24-020945","is_derivative":false,"issuer_cik":"0001422484","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001422484","owner_cik":"0001422484","owner_name":"Mackaness James H","owner_display_name":"Mackaness James H","owner_url":"/insider/0001422484","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6849.0,"shares_display":"6,849","price_per_share":45.7680703022339,"price_display":"45.77","price_state":"stated","total_value":313465.5135,"total_display":"313,465.51","total_whole":"313,466","shares_owned_after":151905.0,"shares_owned_after_display":"151,905","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-05","filed_date":"2024-08-07","scope":"insider","n_lines":2},{"id":2953835,"accession":"0001415889-24-019269","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-019269","line_url":"/filing/0001415889-24-019269","is_derivative":false,"issuer_cik":"0001422484","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001422484","owner_cik":"0001422484","owner_name":"Mackaness James H","owner_display_name":"Mackaness James H","owner_url":"/insider/0001422484","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7190.0,"shares_display":"7,190","price_per_share":41.537360834492354,"price_display":"41.54","price_state":"stated","total_value":298653.6244,"total_display":"298,653.62","total_whole":"298,654","shares_owned_after":55763.0,"shares_owned_after_display":"55,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-01","filed_date":"2024-07-03","scope":"insider","n_lines":2},{"id":2222118,"accession":"0001415889-24-010247","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-010247","line_url":"/filing/0001415889-24-010247","is_derivative":false,"issuer_cik":"0001422484","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001422484","owner_cik":"0001422484","owner_name":"Mackaness James H","owner_display_name":"Mackaness James H","owner_url":"/insider/0001422484","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5175.0,"shares_display":"5,175","price_per_share":41.34056519806763,"price_display":"41.34","price_state":"stated","total_value":213937.4249,"total_display":"213,937.42","total_whole":"213,937","shares_owned_after":65024.0,"shares_owned_after_display":"65,024","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-03","scope":"insider","n_lines":2},{"id":7817229,"accession":"0001209191-23-058576","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-058576","line_url":"/filing/0001209191-23-058576","is_derivative":false,"issuer_cik":"0001422484","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001422484","owner_cik":"0001422484","owner_name":"Mackaness James H","owner_display_name":"Mackaness James H","owner_url":"/insider/0001422484","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32482.0,"shares_display":"32,482","price_per_share":36.4148863247337,"price_display":"36.41","price_state":"stated","total_value":1182828.3376,"total_display":"1,182,828.34","total_whole":"1,182,828","shares_owned_after":12128.0,"shares_owned_after_display":"12,128","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-11","filed_date":"2023-12-13","scope":"insider","n_lines":3},{"id":7837068,"accession":"0001209191-23-057320","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-057320","line_url":"/filing/0001209191-23-057320#line-1","is_derivative":false,"issuer_cik":"0001422484","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001422484","owner_cik":"0001422484","owner_name":"Mackaness James H","owner_display_name":"Mackaness James H","owner_url":"/insider/0001422484","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4186.0,"shares_display":"4,186","price_per_share":28.6519,"price_display":"28.65","price_state":"stated","total_value":119936.8534,"total_display":"119,936.85","total_whole":"119,937","shares_owned_after":21303.0,"shares_owned_after_display":"21,303","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-30","filed_date":"2023-12-04","scope":"insider"},{"id":7900192,"accession":"0001209191-23-057036","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-057036","line_url":"/filing/0001209191-23-057036","is_derivative":false,"issuer_cik":"0001422484","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001422484","owner_cik":"0001422484","owner_name":"Mackaness James H","owner_display_name":"Mackaness James H","owner_url":"/insider/0001422484","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4203.0,"shares_display":"4,203","price_per_share":27.8340431834404,"price_display":"27.83","price_state":"stated","total_value":116986.4835,"total_display":"116,986.48","total_whole":"116,986","shares_owned_after":27530.0,"shares_owned_after_display":"27,530","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-29","filed_date":"2023-11-30","scope":"insider","n_lines":2},{"id":7900185,"accession":"0001209191-23-057036","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-057036","line_url":"/filing/0001209191-23-057036","is_derivative":false,"issuer_cik":"0001422484","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001422484","owner_cik":"0001422484","owner_name":"Mackaness James H","owner_display_name":"Mackaness James H","owner_url":"/insider/0001422484","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3878.0,"shares_display":"3,878","price_per_share":27.124876585869004,"price_display":"27.12","price_state":"stated","total_value":105190.2714,"total_display":"105,190.27","total_whole":"105,190","shares_owned_after":30365.0,"shares_owned_after_display":"30,365","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-28","filed_date":"2023-11-30","scope":"insider","n_lines":2},{"id":6560295,"accession":"0000899243-22-013308","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-013308","line_url":"/filing/0000899243-22-013308#line-1","is_derivative":false,"issuer_cik":"0001422484","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001422484","owner_cik":"0001422484","owner_name":"Mackaness James H","owner_display_name":"Mackaness James H","owner_url":"/insider/0001422484","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":67295.0,"shares_owned_after_display":"67,295","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-31","filed_date":"2022-04-04","scope":"insider"},{"id":4826070,"accession":"0000899243-21-035864","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-035864","line_url":"/filing/0000899243-21-035864#line-1","is_derivative":false,"issuer_cik":"0001422484","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001422484","owner_cik":"0001422484","owner_name":"Mackaness James H","owner_display_name":"Mackaness James H","owner_url":"/insider/0001422484","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11235.0,"shares_display":"11,235","price_per_share":0.8884,"price_display":"0.89","price_state":"stated","total_value":9981.174,"total_display":"9,981.17","total_whole":"9,981","shares_owned_after":27295.0,"shares_owned_after_display":"27,295","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-13","filed_date":"2021-09-14","scope":"insider"},{"id":4662198,"accession":"0000899243-21-035862","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-035862","line_url":"/filing/0000899243-21-035862#line-1","is_derivative":false,"issuer_cik":"0001422484","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001422484","owner_cik":"0001422484","owner_name":"Mackaness James H","owner_display_name":"Mackaness James H","owner_url":"/insider/0001422484","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6060.0,"shares_display":"6,060","price_per_share":1.65,"price_display":"1.65","price_state":"stated","total_value":9999.0,"total_display":"9,999.00","total_whole":"9,999","shares_owned_after":16060.0,"shares_owned_after_display":"16,060","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-26","filed_date":"2021-09-14","scope":"insider"},{"id":6648960,"accession":"0001104659-18-018715","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-018715","line_url":"/filing/0001104659-18-018715#line-1","is_derivative":false,"issuer_cik":"0001393020","issuer_name":"Invuity, Inc.","issuer_ticker":"IVTY","issuer_name_source":null,"issuer_url":"/issuer/0001393020","owner_cik":"0001422484","owner_name":"Mackaness James H","owner_display_name":"Mackaness James H","owner_url":"/insider/0001422484","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2528.0,"shares_display":"2,528","price_per_share":3.8954,"price_display":"3.90","price_state":"stated","total_value":9847.5712,"total_display":"9,847.57","total_whole":"9,848","shares_owned_after":44399.0,"shares_owned_after_display":"44,399","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-16","filed_date":"2018-03-19","scope":"insider"},{"id":2713392,"accession":"0000899243-16-033065","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-033065","line_url":"/filing/0000899243-16-033065#line-1","is_derivative":false,"issuer_cik":"0001393020","issuer_name":"Invuity, Inc.","issuer_ticker":"IVTY","issuer_name_source":null,"issuer_url":"/issuer/0001393020","owner_cik":"0001422484","owner_name":"Mackaness James H","owner_display_name":"Mackaness James H","owner_url":"/insider/0001422484","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1700.0,"shares_display":"1,700","price_per_share":5.75,"price_display":"5.75","price_state":"stated","total_value":9775.0,"total_display":"9,775.00","total_whole":"9,775","shares_owned_after":3700.0,"shares_owned_after_display":"3,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-08","filed_date":"2016-11-09","scope":"insider"},{"id":3194616,"accession":"0000899243-16-020486","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-020486","line_url":"/filing/0000899243-16-020486#line-1","is_derivative":false,"issuer_cik":"0001393020","issuer_name":"Invuity, Inc.","issuer_ticker":"IVTY","issuer_name_source":null,"issuer_url":"/issuer/0001393020","owner_cik":"0001422484","owner_name":"Mackaness James H","owner_display_name":"Mackaness James H","owner_url":"/insider/0001422484","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":5.0777,"price_display":"5.08","price_state":"stated","total_value":10155.4,"total_display":"10,155.40","total_whole":"10,155","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-18","filed_date":"2016-05-19","scope":"insider"},{"id":8634821,"accession":"0001261380-15-000058","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001261380-15-000058","line_url":"/filing/0001261380-15-000058#line-2","is_derivative":false,"issuer_cik":"0001006045","issuer_name":"IRIDEX CORP","issuer_ticker":"IRIX","issuer_name_source":null,"issuer_url":"/issuer/0001006045","owner_cik":"0001422484","owner_name":"Mackaness James H","owner_display_name":"Mackaness James H","owner_url":"/insider/0001422484","role":"Officer (CFO and COO)","role_mark":"O","role_mark_label":"Officer (CFO and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2373.0,"shares_display":"2,373","price_per_share":7.15,"price_display":"7.15","price_state":"stated","total_value":16966.95,"total_display":"16,966.95","total_whole":"16,967","shares_owned_after":45052.0,"shares_owned_after_display":"45,052","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-19","filed_date":"2015-08-21","scope":"insider"},{"id":8922034,"accession":"0001261380-15-000053","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001261380-15-000053","line_url":"/filing/0001261380-15-000053","is_derivative":false,"issuer_cik":"0001006045","issuer_name":"IRIDEX CORP","issuer_ticker":"IRIX","issuer_name_source":null,"issuer_url":"/issuer/0001006045","owner_cik":"0001422484","owner_name":"Mackaness James H","owner_display_name":"Mackaness James H","owner_url":"/insider/0001422484","role":"Officer (CFO and COO)","role_mark":"O","role_mark_label":"Officer (CFO and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2627.0,"shares_display":"2,627","price_per_share":7.102417205938333,"price_display":"7.10","price_state":"stated","total_value":18658.05,"total_display":"18,658.05","total_whole":"18,658","shares_owned_after":44531.0,"shares_owned_after_display":"44,531","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-18","filed_date":"2015-08-19","scope":"insider","n_lines":2},{"id":8922028,"accession":"0001261380-15-000053","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001261380-15-000053","line_url":"/filing/0001261380-15-000053#line-2","is_derivative":false,"issuer_cik":"0001006045","issuer_name":"IRIDEX CORP","issuer_ticker":"IRIX","issuer_name_source":null,"issuer_url":"/issuer/0001006045","owner_cik":"0001422484","owner_name":"Mackaness James H","owner_display_name":"Mackaness James H","owner_url":"/insider/0001422484","role":"Officer (CFO and COO)","role_mark":"O","role_mark_label":"Officer (CFO and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and COO","security_title":"Coommon Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2235.0,"shares_display":"2,235","price_per_share":7.05,"price_display":"7.05","price_state":"stated","total_value":15756.75,"total_display":"15,756.75","total_whole":"15,757","shares_owned_after":44017.0,"shares_owned_after_display":"44,017","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-17","filed_date":"2015-08-19","scope":"insider"},{"id":9280316,"accession":"0001261380-15-000051","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001261380-15-000051","line_url":"/filing/0001261380-15-000051#line-2","is_derivative":false,"issuer_cik":"0001422484","issuer_name":"IRIDEX CORP","issuer_ticker":"IRIX","issuer_name_source":null,"issuer_url":"/issuer/0001422484","owner_cik":"0001422484","owner_name":"Mackaness James H","owner_display_name":"Mackaness James H","owner_url":"/insider/0001422484","role":"Officer (CFO and COO)","role_mark":"O","role_mark_label":"Officer (CFO and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2765.0,"shares_display":"2,765","price_per_share":7.05,"price_display":"7.05","price_state":"stated","total_value":19493.25,"total_display":"19,493.25","total_whole":"19,493","shares_owned_after":43561.0,"shares_owned_after_display":"43,561","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-14","filed_date":"2015-08-18","scope":"insider"},{"id":8728940,"accession":"0001261380-15-000049","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001261380-15-000049","line_url":"/filing/0001261380-15-000049#line-4","is_derivative":false,"issuer_cik":"0001006045","issuer_name":"IRIDEX CORP","issuer_ticker":"IRIX","issuer_name_source":null,"issuer_url":"/issuer/0001006045","owner_cik":"0001422484","owner_name":"Mackaness James H","owner_display_name":"Mackaness James H","owner_url":"/insider/0001422484","role":"Officer (CFO and COO)","role_mark":"O","role_mark_label":"Officer (CFO and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2765.0,"shares_display":"2,765","price_per_share":7.05,"price_display":"7.05","price_state":"stated","total_value":19493.25,"total_display":"19,493.25","total_whole":"19,493","shares_owned_after":43531.0,"shares_owned_after_display":"43,531","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-14","filed_date":"2015-08-17","scope":"insider"},{"id":9280317,"accession":"0001261380-15-000051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001261380-15-000051","line_url":"/filing/0001261380-15-000051#line-1","is_derivative":false,"issuer_cik":"0001422484","issuer_name":"IRIDEX CORP","issuer_ticker":"IRIX","issuer_name_source":null,"issuer_url":"/issuer/0001422484","owner_cik":"0001422484","owner_name":"Mackaness James H","owner_display_name":"Mackaness James H","owner_url":"/insider/0001422484","role":"Officer (CFO and COO)","role_mark":"O","role_mark_label":"Officer (CFO and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":6.95,"price_display":"6.95","price_state":"stated","total_value":34750.0,"total_display":"34,750.00","total_whole":"34,750","shares_owned_after":42996.0,"shares_owned_after_display":"42,996","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-13","filed_date":"2015-08-18","scope":"insider"}],"collapsed":true,"next_cursor":"2015-08-13|9280317","ledger_fault":false,"count":{"value":96,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":89,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":96},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001484565","name":"SOLENO THERAPEUTICS INC","url":"/issuer/0001484565","role":"Officer (CHIEF FINANCIAL OFFICER)","n_filings":13,"first_seen":"2021-09-14","last_seen":"2025-03-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001393020","name":"Invuity, Inc.","url":"/issuer/0001393020","role":"Officer (Chief Financial Officer)","n_filings":3,"first_seen":"2016-05-19","last_seen":"2018-03-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001006045","name":"IRIDEX CORP","url":"/issuer/0001006045","role":"Officer (CFO and COO)","n_filings":22,"first_seen":"2009-03-13","last_seen":"2015-08-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001422484","retrieved_at":"2026-08-25T10:20:26+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}